NeuroscienceFrontiers in ImmunologyPeer-reviewed
Inhibition of IL34 unveils tissue-selectivity and is sufficient to reduce microglial proliferation in chronic neurodegeneration
Juliane Obst, Emilie Simon, María Martín‐Estebané…·Diego Gómez‐Nicola
This study evaluates IL-34 inhibition as a strategy to reduce microglial proliferation in prion disease, showing tissue-selectivity and reduced side effects compared to CSF1R inhibition.
33 citations